Patents by Inventor Guy Rautmann

Guy Rautmann has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Assays for &bgr;-amyloid processing
    Patent number: 6670182
    Abstract: The invention relates to the design, construction and use of eukaryotic cell lines useful in the identification of inhibitors of &bgr;-amyloid processing. More specifically, the invention relates to in vitro assays capable of identifying or quantifying a 4.2 kDa &bgr;-amyloid protein. The present invention also provides for DNA and protein molecules for the design, construction and use of eukaryotic cell lines useful in the identification of inhibitors of &bgr;-amyloid processing.
    Type: Grant
    Filed: February 20, 1998
    Date of Patent: December 30, 2003
    Assignees: Aventis Pharmaceuticals Inc., Scios Nova, Inc.
    Inventors: Rebecca Pruss, John Huggins, Guy Rautmann, Barbara Cordell, Jan Marian Scardina, Ronald P. Mischak
  • Assays for beta-amyloid processing
    Publication number: 20030199094
    Abstract: The invention relates to the design, construction and use of eukaryotic cell lines useful in the identification of inhibitors of &bgr;-amyloid processing. More specifically, the invention relates to in vitro assays capable of identifying or quantifying a 4.2 kDa &bgr;-amyloid protein. The present invention also provides for DNA and protein molecules for the design, construction and use of eukaryotic cell lines useful in the identification of inhibitors of &bgr;-amyloid processing.
    Type: Application
    Filed: May 14, 2003
    Publication date: October 23, 2003
    Inventors: Rebecca Pruss, John Huggins, Guy Rautmann, Barbara Cordell, Jan Marian Scardina, Ronald P. Mischak
  • Viral vector coding for a glycoprotein of the virus responsible for A.I.D.S.
    Patent number: 5795577
    Abstract: This invention relates to an immunogenic composition comprising a viral vector. The genome of the viral vector comprises a functional origin of replication of a poxvirus, a DNA fragment encoding a non-cleavable gp160, a DNA fragment encoding a signal peptide, and a promoter for expressing DNA fragments in mammalian cells.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: August 18, 1998
    Assignees: Transgene S.A., Institut Pasteur
    Inventors: Marie-Paule Kieny, Guy Rautmann, Jean-Pierre Lecocq, Simon Wain Hobson, Marc Girard, Luc Montagnier
  • Non-cleavable GP160 glycoproteins of HIV
    Patent number: 5672689
    Abstract: A viral vector comprising at least a portion of the genome of the HIV virus, a gene encoding gp160 glycoprotein of the envelope of the HIV virus, as well as the elements providing for the expression of the glycoprotein in cells, wherein the gp160 is expressed as a non-cleavable protein.
    Type: Grant
    Filed: May 17, 1995
    Date of Patent: September 30, 1997
    Assignee: Transgene S.A. and Institute Pasteur
    Inventors: Marie-Paule Kieny, Guy Rautmann, Jean-Pierre Lecocq, Simon Wain Hobson, Marc Girard, Luc Montagnier
  • Viral vector coding glycoprotein of HIV-1
    Patent number: 5169763
    Abstract: A viral vector comprising at least a portion of the genome of the HIV virus, a gene coding gp160 glycoprotein of the envelope of the HIV virus, as well as the elements providing for the expression of the glycoprotein in cells, wherein the gp160 is expressed as a non-cleavable protein.
    Type: Grant
    Filed: September 24, 1991
    Date of Patent: December 8, 1992
    Assignee: Transgene S.A., Institut Pasteur
    Inventors: Marie-Paule Kieny, Guy Rautmann, Jean-Pierre Lecocq, Simon W. Hobson, Marc Girard, Luc Montagnier